Dr. Powell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 314-362-3181Fax+1 314-362-2893
Summary
- Dr. Matthew Powell is an obstetrician/gynecologist in Saint Louis, MO and is affiliated with multiple hospitals in the area, including Barnes-Jewish Hospital, Missouri Baptist Sullivan Hospital, Missouri Baptist Medical Center, St. Louis Children's Hospital, Barnes-Jewish West County Hospital, Progress West Hospital, and Siteman Cancer Center. He received his medical degree from Michigan State University College of Human Medicine and has been in practice 22 years. He specializes in critical care medicine, general gynecology, gynecologic oncology, and minimally invasive / endoscopic surgery and is experienced in traumatic brain injury, general obstetrics and gynecology, general gynecology, gynecologic oncology, and urogynecology and pelvic reconstructive surgery. He has more than 300 publications with H-index of 51 (Top 5%), 9793 Citations (Top 5%) 238 Mentions (Top 5%)
Education & Training
- Ohio State University/Mt Carmel HospitalResidency, Obstetrics and Gynecology, 1995 - 1999
- Michigan State University College of Human MedicineClass of 1995
Certifications & Licensure
- IL State Medical License 2002 - 2026
- MO State Medical License 1999 - 2025
- OH State Medical License 1997 - 2010
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients Start of enrollment: 2010 Aug 01
- Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2014 Jul 21
Publications & Presentations
PubMed
- 35 citationsRandomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial.Matthew A Powell, Virginia L Filiaci, Martee L Hensley, Helen Q Huang, Kathleen N Moore
Journal of Clinical Oncology. 2022-03-20 - 187 citationsDisparities in Ovarian Cancer Care Quality and Survival According to Race and Socioeconomic StatusRobert E. Bristow, Matthew A. Powell, Noor Al-Hammadi, Ling Chen, J. Philip Miller
Journal of the National Cancer Institute. 2013-06-05 - 93 citationsPositive peritoneal cytology is an independent risk-factor in early stage endometrial cancer ☆Gunjal Garg, Feng Gao, Jason D. Wright, Andrea R. Hagemann, David G. Mutch
Gynecologic Oncology. 2013-01-01
Journal Articles
- Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian CancerIan S Hagemann, Premal H Thaker, Carolyn K McCourt, Katherine C Fuh, David G Mutch, Andrea R Hagemann, Matthew A Powell, Clinical Cancer Research
- Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous CancerIan S Hagemann, Carolyn K McCourt, Matthew A Powell, Premal H Thaker, David G Mutch, Katherine C Fuh, Andrea R Hagemann, Clinical Cancer Research
Press Mentions
- Powell Named Director of Gynecologic Oncology Division | NewsroomOctober 27th, 2015
- FDA OKs Dostarlimab Plus Chemo for dMMR/MSI-H Endometrial CancerAugust 2nd, 2023
Professional Memberships
- Fellow
- Member
- Member
External Links
- OB GYNhttp://wuphysicians.wustl.edu/physician2.aspx?PhysNum=3010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: